Summary
This study examines Mucuna pruriens extract as a neuroprotective agent in a Parkinson's disease mouse model, finding reductions in neuroinflammation and oxidative stress markers. While not directly related to lighting, findings on neurodegeneration pathways may have peripheral relevance to circadian disruption in Parkinson's disease management.
Key Findings
- Mucuna pruriens extract (100 mg/kg body weight) significantly reduced inflammatory markers (GFAP, iNOS, ICAM, TNF-α) in the substantia nigra pars compacta of MPTP-intoxicated mice
- Mp treatment inhibited NF-κB activation and promoted pAkt1 activity, preventing dopaminergic neuron apoptosis
- Mp significantly restored antioxidant defense by reducing lipid peroxidation and nitrite levels while improving catalase activity and GSH levels in the nigrostriatal region
- Tyrosine hydroxylase and dopamine transporter immunoreactivity were considerably increased following Mp treatment in parkinsonian mice
- HPLC analysis identified L-DOPA, gallic acid, phytic acid, quercetin, and catechin as major active components in the Mp seed extract
Categories
Dementia & Elder Care: The paper investigates neuroprotective treatments in a Parkinson's disease animal model, relevant to neurodegeneration research.
Author(s)
JB Gramsbergen, M Jørgensen
Publication Year
2011
Related Publications
Dementia & Elder Care
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Sleep and circadian rhythms in Parkinson's disease and preclinical models
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
- The clock is ticking. Ageing of the circadian system: from physiology to cell cycle